Using apoferritin as suitable nanocarrier for siRNA to achieve active targeting to cancer cells

Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216305%3A26620%2F18%3APU129751" target="_blank" >RIV/00216305:26620/18:PU129751 - isvavai.cz</a>
Výsledek na webu
—
DOI - Digital Object Identifier
—

Jazyk výsledku
angličtina
Název v původním jazyce
Using apoferritin as suitable nanocarrier for siRNA to achieve active targeting to cancer cells
Popis výsledku v původním jazyce
Small interfering RNA also known as siRNA are a short 21-23 base-pair RNA duplexes. Its leading strand is complementary to a sequence of mRNA. Interaction between mRNA and siRNA leads sequence-specific gene expression suppression, also known as RNA interference (RNAi). RNAi was first discovered in plants and later was demonstrated in Caenorhabditis elegans. Now it is known, that this mechanism can be naturally found also in mammalian cells.
Název v anglickém jazyce
Using apoferritin as suitable nanocarrier for siRNA to achieve active targeting to cancer cells
Popis výsledku anglicky
Small interfering RNA also known as siRNA are a short 21-23 base-pair RNA duplexes. Its leading strand is complementary to a sequence of mRNA. Interaction between mRNA and siRNA leads sequence-specific gene expression suppression, also known as RNA interference (RNAi). RNAi was first discovered in plants and later was demonstrated in Caenorhabditis elegans. Now it is known, that this mechanism can be naturally found also in mammalian cells.

Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění
2018
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Podobné výsledky(10)